These findings underscore an important role of infiltrating CD8<sup>+</sup> T cells in reducing ZIKV-induced CNS inflammation and suggest that modulating their response could serve as a potential therapeutic strategy for ZIKV-associated neurological disease. Here, CD8A is linked to nervous system disorder.